¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ¼öÁ¤ »èÁ¦

´ëÇѾȽŰæÀÇÇÐȸ Neurology of eye movements : 2024-05-18

ÃßõÇϱâ
¿¬¼ö°­Á À̹øÁÖ BEST
 

´ëÇѾȽŰæÀÇÇÐȸ Neurology of eye movements : 2024-05-18
±³À°ÀÏÀÚ : 2024-05-18
±³À°Àå¼Ò : ¼­¿ï ¼­¿ï´ëº´¿ø ÀÇÇבּ¸Çõ½Å¼¾ÅÍ(CMI) 1F ¼­¼ºÈ¯¿¬±¸È¦

±³À°ÁÖÁ¦ : Neurology of eye movements

ÁÖÃÖ±â°ü : ´ëÇѽŰæ°úÇÐȸ
½ÃÇà±â°ü(ÁöºÎ/°ú) : ´ëÇѾȽŰæÀÇÇÐȸ

´ã´çÀÚ : ±èÀ¯Áø
¿¬¶ôó : 02-974-8606

À̸ÞÀÏ : ksno2012@gmail.com

±³À°Á¾·ù : ½Å°æ°ú

Âü¼®¿¹»óÀÎ : 100¸í
Èñ¸ÁÆòÁ¡ : 4Á¡

Áö¿ª : ¼­¿ïƯº°½Ã
±³À°½Ã°£ : 5 ½Ã°£ 5ºÐ

¼¼ºÎ¼ö°­·á : 40,000¿ø  

ºñ°í »çÀüµî·Ïºñ: Àü¹®ÀÇ 30,000, ´çÀϵî·Ïºñ: Àü¹®ÀÇ 40,000 / Àü°øÀÇ ¹«·á


±¸ºÐ ¿ùÀÏ °­ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ

±³À°½Ã°£ 05¿ù 18ÀÏ ¼­¼ºÈ¯¿¬±¸È¦ 09:05~09:25 Transient monocular & binocular blindness ÀÌÁÖ¿µ(°¡Å縯ÀÇ´ë ½Å°æ°ú)

±³À°½Ã°£ 05¿ù 18ÀÏ ¼­¼ºÈ¯¿¬±¸È¦ 09:25~09:45 Ptosis (myogenic, N-M junction, neurogenic) ±ÇÀºÁø(Ãæ³²ÀÇ´ë ½Å°æ°ú)

±³À°½Ã°£ 05¿ù 18ÀÏ ¼­¼ºÈ¯¿¬±¸È¦ 09:45~10:05 Paralytic vs non-paralytic strabismus À±¼Ò¿¬(¿¬¼¼ÀÇ´ë ½Å°æ°ú)

±³À°½Ã°£ 05¿ù 18ÀÏ ¼­¼ºÈ¯¿¬±¸È¦ 10:05~10:25 Anisocoria  °­ÁøÁÖ(ÀüºÏÀÇ´ë ½Å°æ°ú)

Åä·Ð 05¿ù 18ÀÏ ¼­¼ºÈ¯¿¬±¸È¦ 10:25~10:35 Q & A -(-)

ÈÞ½Ä 05¿ù 18ÀÏ ¼­¼ºÈ¯¿¬±¸È¦ 10:35~10:50 ÈÞ½Ä -(-)

±³À°½Ã°£ 05¿ù 18ÀÏ ¼­¼ºÈ¯¿¬±¸È¦ 10:50~11:15 Understanding of eye movement and objective measurement ÀÓÇÑ¿õ(ÇѾçÀÇ´ë ¾È°ú)

±³À°½Ã°£ 05¿ù 18ÀÏ ¼­¼ºÈ¯¿¬±¸È¦ 11:15~11:40 Eye movement recording using virtual reality and deep-learning model È«¼º±¤(ÇѸ²ÀÇ´ë À̺ñÀÎÈÄ°ú)

±³À°½Ã°£ 05¿ù 18ÀÏ ¼­¼ºÈ¯¿¬±¸È¦ 11:40~12:00 Saccadic analysis: update  ÃÖ¼­¿µ(ºÎ»êÀÇ´ë ½Å°æ°ú)

Åä·Ð 05¿ù 18ÀÏ ¼­¼ºÈ¯¿¬±¸È¦ 12:00~12:10 Q & A -(-)

½Ä»ç 05¿ù 18ÀÏ ¼­¼ºÈ¯¿¬±¸È¦ 12:10~13:10 ÃÑȸ ¹× Lunch -(-)

±³À°½Ã°£ 05¿ù 18ÀÏ ¼­¼ºÈ¯¿¬±¸È¦ 13:10~13:35 Afferent visual symptoms and traumatic optic neuropathy  ½ÅÇöÁø(°Ç±¹ÀÇ´ë ¾È°ú)

±³À°½Ã°£ 05¿ù 18ÀÏ ¼­¼ºÈ¯¿¬±¸È¦ 13:35~13:55 Efferent visual symptoms and eye movement abnormalities    ÀÌÀͼº(¼øõÇâÀÇ´ë ½Å°æ°ú)

±³À°½Ã°£ 05¿ù 18ÀÏ ¼­¼ºÈ¯¿¬±¸È¦ 13:55~14:15 Post-traumatic dizziness Á¤ÀϾï(°Ç±¹ÀÇ´ë ½Å°æ°ú)

Åä·Ð 05¿ù 18ÀÏ ¼­¼ºÈ¯¿¬±¸È¦ 14:15~14:25 Q & A -(-)

ÈÞ½Ä 05¿ù 18ÀÏ ¼­¼ºÈ¯¿¬±¸È¦ 14:25~14:40 ÈÞ½Ä -(-)

±³À°½Ã°£ 05¿ù 18ÀÏ ¼­¼ºÈ¯¿¬±¸È¦ 14:40~14:55 (±¸¿¬¹ßÇ¥)ANCA-associated pachymeningitis and bilateral optic neuropathy treated with steroid pulse therapy        ±èÈ«³²(¾ÆÁÖÀÇ´ë ½Å°æ°ú)

±³À°½Ã°£ 05¿ù 18ÀÏ ¼­¼ºÈ¯¿¬±¸È¦ 14:55~15:10 (±¸¿¬¹ßÇ¥)Clinical Characteristics and Genetic Analysis of Chronic Progressive External Ophthalmoplegia À̼÷¹Î(ºÎ»êÀÇ´ë ½Å°æ°ú)

±³À°½Ã°£ 05¿ù 18ÀÏ ¼­¼ºÈ¯¿¬±¸È¦ 15:10~15:25 (±¸¿¬¹ßÇ¥)Neuro-ophthalmologic and neuro-otologic findings in spinocerebellar ataxia type 7 ±èÀç¸í(Àü³²ÀÇ´ë ½Å°æ°ú)

±³À°½Ã°£ 05¿ù 18ÀÏ ¼­¼ºÈ¯¿¬±¸È¦ 15:25~15:40 (±¸¿¬¹ßÇ¥)Hypertensive optic neuropathy    ¹ÚÁöÀ±(¿ï»êÀÇ´ë ½Å°æ°ú)

 

ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" ´ëÇѾȽŰæÀÇÇÐȸ Neurology of eye movements : 2024-05-18""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ¼öÁ¤ »èÁ¦
ÀÌÀü±Û 2024³â ´ëÀü±¤¿ª½ÃÀÇ»çȸ Ãá°èÇмú´ëȸ : 2024-05-18
´ÙÀ½±Û ´ëÇÑÁ¾¾ç³»°úÇÐȸ KSMO Á¦ 22Â÷ Ãá°èÁ¤±â½ÉÆ÷Áö¾ö ¹× ÃÑȸ : 2024-05-17
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
647 Á¦ÁÖ ´ëÇѳúÀüÁõÇÐȸ Á¦6Â÷ ÄÉÅæ»ý¼º ½ÄÀÌÄ¡·á ±Û·Î¹ú ½ÉÆ÷Áö¾ö (6th Global Symposium on Ketogenic Therapies for Neurological Disorders) : 2018-10-09 0 542 2018-08-29
646 Á¦ÁÖ ´ëÇѳúÀüÁõÇÐȸ Á¦6Â÷ ÄÉÅæ»ý¼º ½ÄÀÌÄ¡·á ±Û·Î¹ú ½ÉÆ÷Áö¾ö (6th Global Symposium on Ketogenic Therapies for Neurological Disorders) : 2018-10-08 0 562 2018-08-29
645 Á¦ÁÖ ´ëÇѳúÀüÁõÇÐȸ Á¦6Â÷ ÄÉÅæ»ý¼º ½ÄÀÌÄ¡·á ±Û·Î¹ú ½ÉÆ÷Áö¾ö (6th Global Symposium on Ketogenic Therapies for Neurological Disorders) : 2018-10-07 0 787 2018-08-29
644 ¼­¿ï ¿¬¼¼´ëÇб³ ¼¼ºê¶õ½ºº´¿ø ´ëÇÑ°üÀý°æÇÐȸ Á¦9ȸ ¿¬¼ö°­Á : 2018-10-07 0 563 2018-08-29
643 ¼­¿ï ¼­¿ï´ëÇб³º´¿ø Á¦ 18ȸ ºÎÀÎ¾Ï ½ÉÆ÷Áö¿ò : 2018-10-07 0 595 2018-08-29
642 ¼­¿ï 2018 Çѱ¹Á¤½ÅºÐ¼®ÇÐȸ Á¤½ÅÄ¡·á Àü¹®°úÁ¤ : ÇÇÇмº ÀΰÝÀå¾Ö, ¿ì¿ï¼º ÀΰÝÀå¾Ö : 2018-10-06 0 1,070 2018-08-29
641 Àü³² 2018³â Á¦2Â÷ ÀÇ¿ø ¹× º´¿ø±Þ ÀÇ·á±â°ü ÇÁ·ÎÆ÷Æú ÁøÁ¤±³À° "ÀÇ»çÇùȸ ¹× °£È£Çùȸ ÀÎÁõ" : 2018-10-06 0 874 2018-08-29
640 Á¦ÁÖ ´ëÇѳúÀüÁõÇÐȸ Á¦6Â÷ ÄÉÅæ»ý¼º ½ÄÀÌÄ¡·á ±Û·Î¹ú ½ÉÆ÷Áö¾ö (6th Global Symposium on Ketogenic Therapies for Neurological Disorders) : 2018-10-06 0 433 2018-08-29
639 ¼­¿ï °­³²¼¼ºê¶õ½ºº´¿ø Hybrid Aortic Live Symposium : 2018-10-06 0 706 2018-08-29
638 °æ±â 2018 ÀÎÁ¦´ëÇб³ ÀÏ»ê¹éº´¿ø ½Å°æ°ú °³¿øÀÇ ¿¬¼ö°­Á : 2018-10-06 0 627 2018-08-29
637 ¼­¿ï 2018 Ç¥ÀûÄ¡·á¿¬±¸È¸ Ãß°è½ÉÆ÷Áö¾ö : 2018-10-06 0 513 2018-08-29
636 ¼­¿ï Á¦38Â÷ ´ëÇÑ°üÀý°æÇÐȸ Ãß°èÇмú´ëȸ : 2018-10-06 0 494 2018-08-29
635 °æ³² »ï¼ºÃ¢¿øº´¿ø 2018³â ¼º±Õ°ü´ëÇб³ SMC Changwon ½Å°æ¿Ü°úÇÐ ¿¬¼ö°­Á : 2018-10-06 0 984 2018-08-29
634 ÀÎõ 2018³â ÀÎÇϴ뺴¿ø ³»°ú °³¿øÀÇ ¿¬¼ö°­Á : 2018-10-06 0 787 2018-08-29
633 ¼­¿ï ¼­¿ï¾Æ»êº´¿ø Á¦11ȸ ¾Æ»ê±¹Á¦¼ÒÈ­±âº´½ÉÆ÷Áö¾ö(AIDDS) 2018 : 2018-10-06 0 578 2018-08-29
1371 | 1372 | 1373 | 1374 | 1375 | 1376 | 1377 | 1378 | 1379 | 1380
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷